CoChat

The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease

Open access
Engelmann, Cornelius, Tacke, Frank · 2022 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Abstract

Non-alcoholic fatty liver disease (NAFLD) represents an increasing global health burden. Cellular senescence develops in response to cellular injury, leading not only to cell cycle arrest but also to alterations of the cellular phenotype and metabolic functions. In this review, we critically discuss the currently existing evidence for the involvement of cellular senescence in NAFLD in order to identify areas requiring further exploration. Hepatocyte senescence can be a central pathomechanism as it may foster intracellular fat accumulation, fibrosis and inflammation, also due to secretion of senescence-associated inflammatory mediators. However, in some non-parenchymal liver cell types, such as hepatic stellate cells, senescence may be beneficial by reducing the extracellular matrix deposition and thereby reducing fibrosis. Deciphering the detailed interaction between NAFLD and cellular senescence will be essential to discover novel therapeutic targets halting disease progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms23020652

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Disease progression in fatty liver disease. Obesity and metabolic disorders represent risk factors for NAFLD, which starts with fat accumulation in hepatocytes. Further disease progression is characterized by inflammation (NASH) and subsequent fibrogenesis leading to cirrhosis. NASH with and without cirrhosis bears the risk of developing hepatocellular carcinoma (HCC) [5,6,20].
Figure 1 Disease progression in fatty liver disease. Obesity and metabolic disorders represent risk factors for NAFLD, which starts with fat accumulation in hepatocytes. Further disease progression is characterized by inflammation (NASH) and subsequent fibrogenesis leading to cirrhosis. NASH with and without cirrhosis bears the risk of developing hepatocellular carcinoma (HCC) [5,6,20].CC BY · PubMed Central
Figure 2 Mechanisms of cellular senescence. Cellular senescence can have various triggers such as telomere shortening, DNA damage, oncogene activation and mitochondria-related factors such as reactive oxygen species (ROS) and mitochondrial DNA damage. Upon injury, the DNA damage response (DDR) mechanisms are activated and signal transduction through protein phosphorylation of ATM, ATR, CHKs stabilizes p53, thus inducing cell cycle arrest through RB. Senescence cells show high expression of p16 and p21 and high activity of SA-β-gal and secrete cytokines and chemoattractants via SASP (modified from Di Micco R et al. [30]).
Figure 2 Mechanisms of cellular senescence. Cellular senescence can have various triggers such as telomere shortening, DNA damage, oncogene activation and mitochondria-related factors such as reactive oxygen species (ROS) and mitochondrial DNA damage. Upon injury, the DNA damage response (DDR) mechanisms are activated and signal transduction through protein phosphorylation of ATM, ATR, CHKs stabilizes p53, thus inducing cell cycle arrest through RB. Senescence cells show high expression of p16 and p21 and high activity of SA-β-gal and secrete cytokines and chemoattractants via SASP (modified from Di Micco R et al. [30]).CC BY · PubMed Central
Figure 3 The potential role of cellular senescence in NAFLD progression. Hepatocellular senescence and mitochondrial dysfunction may aggravate fat accumulation in hepatocytes. The senescence-associated secretory phenotype (SASP) initiates recruitment of monocytes and neutrophils, thereby inducing inflammation and transition to NASH. In the same manner, SASP activates hepatic stellate cells leading to fibrogenesis.
Figure 3 The potential role of cellular senescence in NAFLD progression. Hepatocellular senescence and mitochondrial dysfunction may aggravate fat accumulation in hepatocytes. The senescence-associated secretory phenotype (SASP) initiates recruitment of monocytes and neutrophils, thereby inducing inflammation and transition to NASH. In the same manner, SASP activates hepatic stellate cells leading to fibrogenesis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 69

Metadata

Authors
Engelmann, C., & Tacke, F.
Affiliations
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
  • Charité – Universitätsmedizin Berlin (DE)
Corresponding author
Engelmann, Cornelius
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-01-07
Volume
23
Issue
2
Pages
652
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4205372104
Cited by
61
References
90
Citations by year
2026: 13 · 2025: 12 · 2024: 14 · 2023: 10 · 2022: 12
FWCI
1.91
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by)
  • Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver (cc-by)
Funders
  • Bristol-Myers Squibb
  • Gilead Sciences
  • CSL Behring
  • Berlin Institute of Health
  • Allergan
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
cellular senescence, non-alcoholic fatty liver disease, hepatocyte senescence, hepatic stellate cells, liver fibrosis, senescence-associated inflammation, extracellular matrix deposition, therapeutic target
MeSH terms
Extracellular Matrix, Humans, Cellular Senescence, Disease Progression, Hepatocytes, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.